One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v130.suppl_1.4048.4048
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 3 |
Affiliation: Incyte (United States), Hematology Oncology Associates, University of California, San Diego, University of North Carolina at Chapel Hill, University of Michigan–Ann Arbor, Yale University, Atrium Health Wake Forest Baptist, University of Minnesota, Washington University in St. Louis, University of Alabama at Birmingham, University of Rochester, Hematology Oncology Consultants, Sylvester Comprehensive Cancer Center, Sarah Cannon, HealthONEPreliminary Results from an Ongoing Phase 1/2 Study of INCB057643, a Bromodomain and Extraterminal (BET) Protein Inhibitor, in Patients (pts) with Advanced Malignancies
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
